Genetic alterations of IDH1 and Vegf in brain tumors

Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies

(2015) Liang Xia et al.   Oncotarget

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

(2015) Patrick J. Killela et al.   Oncotarget

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

(2014) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

IDH1/2 mutation detection in gliomas

(2014) Hideyuki Arita et al.   Brain Tumor Pathology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer

(2014) José Augusto Rinck-Junior et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation

(2014) Jinlong Shi et al.   TUMOR BIOLOGY

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia

(2014) J. Polivka et al.   Biomed Research International

The Somatic Genomic Landscape of Glioblastoma

(2013) Cameron W. Brennan et al.   CELL

Three single nucleotide polymorphisms of the vascular endothelial growth factor (VEGF) gene and glioma risk in a Chinese population

(2013) Haitao Jiang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis

(2013) Hairui Sun et al.   JOURNAL OF NEURO-ONCOLOGY

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients

(2013) Marzena Anna Lewandowska et al.   Molecular Diagnosis & Therapy

Mutation Analysis of IDH1 in Paired Gliomas Revealed IDH1 Mutation Was Not Associated with Malignant Progression but Predicted Longer Survival

(2013) Yu Yao et al.   PLoS One

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

(2012) Benjamin Ellezam et al.   ACTA NEUROPATHOLOGICA

IDH1 Mutations in Diffusely Infiltrating Astrocytomas

(2012) Balaram Thota et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

(2012) J.A. Carrillo et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Infratentorial low-grade oligoastrocytoma with aggressive clinical behavior in an adult: a case report with genetic characterization

(2012) Keisho Sano et al.   Brain Tumor Pathology

The single-nucleotide polymorphisms +936 C/T VEGF and −710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population

(2012) Patricia Rodrigues et al.   BREAST CANCER RESEARCH AND TREATMENT

Recent advances in the molecular understanding of glioblastoma

(2012) Fonnet E. Bleeker et al.   JOURNAL OF NEURO-ONCOLOGY

Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors

(2012) Shingo Takano et al.   JOURNAL OF NEURO-ONCOLOGY

IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas

(2012) Tareq A. Juratli et al.   JOURNAL OF NEURO-ONCOLOGY

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

(2012) Sevin Turcan et al.   NATURE

Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults

(2011) Adriana Olar et al.   Annals of Diagnostic Pathology

New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status

(2011) Ichiyo Shibahara et al.   Brain Tumor Pathology

Predictive and prognostic factors for gliomas

(2011) François Ducray et al.   Expert Review of Anticancer Therapy

Isocitrate dehydrogenase mutations: A challenge to traditional views on the genesis and malignant progression of gliomas

(2011) Michael Weller et al.   GLIA

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors

(2011) Marta Mellai et al.   JOURNAL OF NEURO-ONCOLOGY

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

(2010) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis

(2010) Dae Sik Yang et al.   BREAST CANCER RESEARCH AND TREATMENT

Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population

(2010) Rui Li et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

(2010) S. Sjöström et al.   JOURNAL OF NEURO-ONCOLOGY

Characterization and outcomes of infratentorial malignant glioma: A population-based study using the Surveillance Epidemiology and End-Results database

(2010) Justin Rineer et al.   RADIOTHERAPY AND ONCOLOGY

IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas

(2009) Takuya Watanabe et al.   AMERICAN JOURNAL OF PATHOLOGY

PCR- and Restriction Endonuclease-Based Detection ofIDH1Mutations

(2009) Jochen Meyer et al.   BRAIN PATHOLOGY

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

(2009) Michael Weller et al.   JOURNAL OF CLINICAL ONCOLOGY

Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

(2009) Marc Sanson et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma

(2009) H. Quon et al.   JOURNAL OF NEURO-ONCOLOGY

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

(2009) Koichi Ichimura et al.   NEURO-ONCOLOGY

Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 

(2009) S. Zhao et al.   SCIENCE

The VEGF_936_C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women

(2008) Anna Jakubowska et al.   CANCER LETTERS

Genetic characterization of adult infratentorial gliomas

(2008) Tomoru Miwa et al.   JOURNAL OF NEURO-ONCOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE